spacer
home > pmps
PUBLICATIONS

Pharmaceutical Manufacturing and Packing Sourcer

 

Pharmaceutical Manufacturing and Packing Sourcer (PMPS) is a specialist journal designed to provide worldwide coverage of a range of topics relating to the pharmaceutical manufacturing and packaging sector.

Published quarterly, the journal functions as a platform of communication and information-sharing for executive and strategic decision-makers within the industry, identifying new trends and marketing opportunities as well as highlighting the latest innovations in this dynamic environment. PMPS is specifically designed to interest those in the pharmaceutical, biotech, nutritional and medical device industries who are actively seeking to source services for improved efficiency in what is an increasingly competitive market.




 
For further information please contact:

Advertising
Nicholas Matthews

Editorial
Amy McKavanagh

We're also on Twitter! Follow us @PMPSmag  

Read our publications on the go in the Samedan app for iPhone and iPad. You can download issues for offline reading and our archives go as far back as 2008! Download for free on the App Store.


Click here to view the digital version of PMPS

 


  Click here to view the digital version of Parenteral Technology
 

pmps
 
 
Featured in this issue
Labelling
Compliance Challenges

Labelling Matters


Non-adherence is a growing issue that can partially be linked to a lack of attention to labelling. Mark Cusworth at PRISYM ID suggests that a data-driven approach will allow greater flexibility, lower costs and strengthen compliance.
Formulation, Ingredients & Excipients
Excipient Selection

Reducing Risks


Pharma products are expected to be curative and safe. Croda Europe’s Anthony Hubbard explains how excipient selection affects this, as well as expenses and speed to market.
  Supply Chain
Product Lifecycle

Supply Uninterrupted


Elles Steensma at GE Healthcare looks at the difficulties in supplier selection when establishing an effective biopharmaceutical manufacturing environment.

spacer
Edited by
Robert Harris
Chief Technical Officer at Juniper Pharma Services
Published quarterly in
February, May,
August and November


Widgets Magazine
 

Industry Events

14th Annual Biomarkers & Immuno-Oncology World Congress

11-13 June 2018, Westin Boston Waterfront, Boston, Massachusetts

The Biomarkers and Immuno-Oncology World Congress brings together a unique and international mix of large and medium pharmaceutical, biotech and diagnostics companies, leading universities and clinical research institutions, government and national labs, CROs, emerging companies and tool providers—making the Congress a perfect meeting-place to share experience, foster collaborations across industry and academia, and evaluate emerging technologies.
More info >>

 
News and Press Releases

Positive results from first preclinical in-vivo studies of Affimer therapeutics


More info >>

air transport logo

 

White Papers

The Importance of ADCC in Assessing Clinically Relevant Differences

Sartorius Stedim BioOutsource Ltd

Biosimilars have caused a revolution in the development of biologic drugs. The model for biosimilars is a combination of speed to market and low cost; these are fundamental to any biosimilar development project. The biosimilars pathway to approval is not always without difficulty, biosimilars are still relatively new, and as each new applicant is reviewed we are learning more and more about these molecules.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement